Dobbs Kerry, Domínguez Conde Cecilia, Zhang Shen-Ying, Parolini Silvia, Audry Magali, Chou Janet, Haapaniemi Emma, Keles Sevgi, Bilic Ivan, Okada Satoshi, Massaad Michel J, Rounioja Samuli, Alwahadneh Adel M, Serwas Nina K, Capuder Kelly, Çiftçi Ergin, Felgentreff Kerstin, Ohsumi Toshiro K, Pedergnana Vincent, Boisson Bertrand, Haskoloğlu Şule, Ensari Arzu, Schuster Michael, Moretta Alessandro, Itan Yuval, Patrizi Ornella, Rozenberg Flore, Lebon Pierre, Saarela Janna, Knip Mikael, Petrovski Slavé, Goldstein David B, Parrott Roberta E, Savas Berna, Schambach Axel, Tabellini Giovanna, Bock Christoph, Chatila Talal A, Comeau Anne Marie, Geha Raif S, Abel Laurent, Buckley Rebecca H, İkincioğulları Aydan, Al-Herz Waleed, Helminen Merja, Doğu Figen, Casanova Jean-Laurent, Boztuğ Kaan, Notarangelo Luigi D
From the Division of Immunology (K.D., J.C., S.K., M.J.M., K.C., K.F., T.A.C., R.S.G., L.D.N.) and Manton Center for Orphan Disease Research (L.D.N.), Boston Children's Hospital, and Department of Molecular Biology, Massachusetts General Hospital (T.K.O.), Boston, Harvard Stem Cell Institute, Harvard University, Cambridge (L.D.N.), and Department of Pediatrics, University of Massachusetts Medical School, Worcester (A.M.C.) - all in Massachusetts; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (C.D.C., I.B., N.K.S., M.S., C.B., K.B.), Department of Pediatrics and Adolescent Medicine, Medical University of Vienna (K.B.), and CeRUD Vienna Center for Rare and Undiagnosed Diseases (K.B.) - all in Vienna; St. Giles Laboratory of Human Genetics of Infectious Disease, Rockefeller Branch, Rockefeller University (S.-Y.Z., M.A., S.O., B.B., Y.I., L.A., J.-L.C.), and Institute for Genomic Medicine, Columbia University (S. Petrovski, D.B.G.) - both in New York; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM Unité 1163 (S.-Y.Z., V.P., L.A., J.-L.C.), Paris Descartes University, Sorbonne Paris Cité, Imagine Institute (S.-Y.Z., F.R., P.L., L.A., J.-L.C.), and Pediatric Hematology-Immunology Unit, Necker Hospital for Sick Children (J.-L.C.) - all in Paris; Howard Hughes Medical Institute, Chevy Chase, MD (J.-L.C.); Department of Molecular and Translational Medicine, University of Brescia, Brescia (S. Parolini, O.P., G.T.), and Department of Experimental Medicine and Center of Excellence for Biomedical Research, University of Genoa, Genoa (A.M.) - both in Italy; Folkhälsan Institute of Genetics and Research Programs Unit, Molecular Neurology (E.H.), Institute for Molecular Medicine Finland (J.S.), Children's Hospital (M.K.), Research Programs Unit, Diabetes and Obesity Research Program (M.K.), and Folkhälsan Research Center (M.K.), University of Helsinki and Helsinki University Central Hospital, Helsinki, Tampere Center
N Engl J Med. 2015 Jun 18;372(25):2409-22. doi: 10.1056/NEJMoa1413462.
Background Combined immunodeficiencies are marked by inborn errors of T-cell immunity in which the T cells that are present are quantitatively or functionally deficient. Impaired humoral immunity is also common. Patients have severe infections, autoimmunity, or both. The specific molecular, cellular, and clinical features of many types of combined immunodeficiencies remain unknown. Methods We performed genetic and cellular immunologic studies involving five unrelated children with early-onset invasive bacterial and viral infections, lymphopenia, and defective T-cell, B-cell, and natural killer (NK)-cell responses. Two patients died early in childhood; after allogeneic hematopoietic stem-cell transplantation, the other three had normalization of T-cell function and clinical improvement. Results We identified biallelic mutations in the dedicator of cytokinesis 2 gene (DOCK2) in these five patients. RAC1 activation was impaired in the T cells. Chemokine-induced migration and actin polymerization were defective in the T cells, B cells, and NK cells. NK-cell degranulation was also affected. Interferon-α and interferon-λ production by peripheral-blood mononuclear cells was diminished after viral infection. Moreover, in DOCK2-deficient fibroblasts, viral replication was increased and virus-induced cell death was enhanced; these conditions were normalized by treatment with interferon alfa-2b or after expression of wild-type DOCK2. Conclusions Autosomal recessive DOCK2 deficiency is a new mendelian disorder with pleiotropic defects of hematopoietic and nonhematopoietic immunity. Children with clinical features of combined immunodeficiencies, especially with early-onset, invasive infections, may have this condition. (Supported by the National Institutes of Health and others.).
背景 联合免疫缺陷以T细胞免疫的先天性缺陷为特征,即存在的T细胞在数量或功能上存在缺陷。体液免疫受损也很常见。患者会出现严重感染、自身免疫或两者皆有。许多类型联合免疫缺陷的具体分子、细胞和临床特征仍不清楚。方法 我们对5名患有早发性侵袭性细菌和病毒感染、淋巴细胞减少以及T细胞、B细胞和自然杀伤(NK)细胞反应缺陷的无关儿童进行了基因和细胞免疫学研究。2名患者在儿童早期死亡;在接受异基因造血干细胞移植后,另外3名患者的T细胞功能恢复正常,临床症状改善。结果 我们在这5名患者中发现了细胞分裂素2基因(DOCK2)的双等位基因突变。T细胞中的RAC1激活受损。趋化因子诱导的迁移和肌动蛋白聚合在T细胞、B细胞和NK细胞中存在缺陷。NK细胞脱颗粒也受到影响。病毒感染后外周血单核细胞产生的干扰素-α和干扰素-λ减少。此外,在DOCK2缺陷的成纤维细胞中,病毒复制增加,病毒诱导的细胞死亡增强;用干扰素α-2b治疗或表达野生型DOCK2后,这些情况恢复正常。结论 常染色体隐性DOCK2缺陷是一种新的孟德尔疾病,具有造血和非造血免疫的多效性缺陷。具有联合免疫缺陷临床特征的儿童,尤其是有早发性侵袭性感染的儿童,可能患有这种疾病。(由美国国立卫生研究院等资助。)